An Expanded Access Program of Garetosmab in Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)
Clinical trial NCT07301450 · TEMPORARILY_NOT_AVAILABLE
Trial details
- NCT number
- NCT07301450
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TEMPORARILY_NOT_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.